Xiaoling Fu

696 total citations
21 papers, 269 citations indexed

About

Xiaoling Fu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoling Fu has authored 21 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoling Fu's work include Colorectal Cancer Treatments and Studies (3 papers), Law, AI, and Intellectual Property (2 papers) and Phytochemistry and Bioactive Compounds (1 paper). Xiaoling Fu is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Law, AI, and Intellectual Property (2 papers) and Phytochemistry and Bioactive Compounds (1 paper). Xiaoling Fu collaborates with scholars based in China, United States and India. Xiaoling Fu's co-authors include Hua Sui, Qi Li, Zhe‐Sheng Chen, Huirong Zhu, Qing Ji, Jianping Huang, Yali Zhang, Xuan Liu, Wanli Deng and Huayue Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cellular Biochemistry and Oncotarget.

In The Last Decade

Xiaoling Fu

21 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Fu China 10 104 53 34 27 27 21 269
Jinglong Yan China 12 133 1.3× 28 0.5× 25 0.7× 19 0.7× 21 0.8× 22 366
Xingping Quan Macao 12 217 2.1× 33 0.6× 52 1.5× 33 1.2× 25 0.9× 24 403
Tzu‐Yu Lin Taiwan 11 199 1.9× 35 0.7× 46 1.4× 29 1.1× 19 0.7× 21 401
Silvia Sostegni Australia 5 132 1.3× 35 0.7× 57 1.7× 32 1.2× 13 0.5× 6 392
Yuchen Lin China 10 195 1.9× 48 0.9× 22 0.6× 12 0.4× 25 0.9× 24 542
Sunny Li‐Yun Chang Taiwan 13 150 1.4× 44 0.8× 48 1.4× 29 1.1× 15 0.6× 25 329
Jianyuan Gao China 9 127 1.2× 35 0.7× 31 0.9× 21 0.8× 9 0.3× 16 334
Ruowu Shen China 11 117 1.1× 56 1.1× 50 1.5× 19 0.7× 10 0.4× 21 300

Countries citing papers authored by Xiaoling Fu

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Fu more than expected).

Fields of papers citing papers by Xiaoling Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Fu. The network helps show where Xiaoling Fu may publish in the future.

Co-authorship network of co-authors of Xiaoling Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Fu. A scholar is included among the top collaborators of Xiaoling Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Fu. Xiaoling Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Xiaoling, et al.. (2023). Research on Copyright Protection of Film and TV Series in the Era of Short Video Deluge in China. 4(2). p65–p65. 1 indexed citations
2.
3.
Fu, Xiaoling, et al.. (2023). Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond. Drug Resistance Updates. 68. 100935–100935. 26 indexed citations
4.
5.
6.
Meng, Xiangxue, et al.. (2021). Bioinformatics Analysis to Screen Key Targets of Curcumin against Colorectal Cancer and the Correlation with Tumor-Infiltrating Immune Cells. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 8 indexed citations
7.
Meng, Xiangxue, et al.. (2021). Exploring the Mechanism of Action of Canmei Formula Against Colorectal Adenoma Through Multi-Omics Technique. Frontiers in Cell and Developmental Biology. 9. 778826–778826. 8 indexed citations
8.
Cheng, Zhihong, et al.. (2021). Transcriptomic and Proteomic Study on the High-Fat Diet Combined With AOM/DSS-Induced Adenomatous Polyps in Mice. Frontiers in Oncology. 11. 736225–736225. 9 indexed citations
9.
10.
Fu, Xiaoling, et al.. (2021). [Genetic Polymorphism of Antigens in Twelve Rare Blood Group Systems of Li Nationality in Hainan Province].. PubMed. 29(3). 917–923. 2 indexed citations
11.
Zhang, Huayue, et al.. (2020). Roles of Fibulin-2 in Carcinogenesis. Medical Science Monitor. 26. e918099–e918099. 16 indexed citations
12.
Fu, Xiaoling, Yanbo Zhang, Ru Jia, et al.. (2020). The JPJDF has Synergistic Effect with Fluoropyrimidine in the Maintenance Therapy for Metastatic Colorectal Cancer. Recent Patents on Anti-Cancer Drug Discovery. 15(3). 257–269. 3 indexed citations
13.
Fu, Xiaoling, et al.. (2019). <p>The impact of the interval between the induction of chemotherapy and radiotherapy on the survival of patients with nasopharyngeal carcinoma</p>. Cancer Management and Research. Volume 11. 2313–2320. 5 indexed citations
14.
Fu, Xiaoling, Weixin Niu, Ji Li, et al.. (2017). Activating mutation ofPDGFRBgene in a rare cardiac undifferentiated intimal sarcoma of the left atrium: a case report. Oncotarget. 8(46). 81709–81716. 12 indexed citations
15.
Wang, Jifeng, Xin Sui, Nan Xu, et al.. (2017). Effects of Different Land Use on Soil Bacterial Functional Diversity in Sanjiang Plain, Northeast China. Journal of Residuals Science and Technology. 14(1). 91–98. 6 indexed citations
16.
Fu, Xiaoling, et al.. (2016). Long-Term Alcohol-Induced Activation of Mammalian Target of Rapamycin is a Key Risk Factor of Epilepsy. Medical Science Monitor. 22. 3975–3980. 10 indexed citations
17.
Sui, Hua, Lihong Zhou, Yali Zhang, et al.. (2015). Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF‐κB Pathway in Colorectal Cancer. Journal of Cellular Biochemistry. 117(6). 1471–1481. 55 indexed citations
18.
19.
Liu, Ningning, Qiong Wu, Hua Sui, et al.. (2014). Helicobacter pylori promotes VEGF expression via the p38 MAPK-mediated COX-2-PGE2 pathway in MKN45 cells. Molecular Medicine Reports. 10(4). 2123–2129. 17 indexed citations
20.
Sui, Hua, Xuan Liu, Lihong Zhou, et al.. (2014). Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway. BMC Complementary and Alternative Medicine. 14(1). 279–279. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinglong Yan Breakdown of academic impact, for papers by Xingping Quan Breakdown of academic impact, for papers by Tzu‐Yu Lin Breakdown of academic impact, for papers by Silvia Sostegni Breakdown of academic impact, for papers by Yuchen Lin Breakdown of academic impact, for papers by Sunny Li‐Yun Chang Breakdown of academic impact, for papers by Jianyuan Gao Breakdown of academic impact, for papers by Ruowu Shen
Rankless by CCL
2026